The AdventHealth Cancer Institute recently released recommendations for prostate cancer screening.
At age 40 men with greater than 10-15 year life expectancy should be risk stratified and considered for prostate cancer screening.
Doctors should start conversing with men about the potential benefits, uncertainties, and risks of prostate cancer screening in the following risk categories:
- Very high risk - (men with more than one first degree relative) begin the conversation at age 40.
- High risk - (men of African American descent and/or those who have a single first degree relative - father, brother or son diagnosed with prostate cancer before age 65) begin the conversation at age 45.
- Average risk - begin conversation at age 50.
Testing should include the PSA blood test and digital rectal exam.
Those with less than 10-15 year life expectancy should not be offered prostate cancer screening.
The exact interval (yearly, biennial, or every 4 years) of subsequent prostate cancer screenings are still uncertain and the pros and cons of future screening intervals should be discussed with each patient.
*These recommendations are adopted based upon the guidance of our FHCI expert panel and with consideration of the American Cancer Society Recommendations on Prostate Cancer Screening and the American Urological Association (AUA) Guideline.